Home > Insider Trading > Filing (0001209191-21-058506)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408500	E Martin Cearnal	2525 West End Ave. Suite 950 Nashville TN 37203	Sr Vp/Chief Commercial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-01	105	$2.88	169,569	No	4	P	Direct
Common Stock	Acquisiton	2021-09-02	105	$2.88	169,674	No	4	P	Direct
Common Stock	Acquisiton	2021-09-03	105	$2.85	169,779	No	4	P	Direct
Common Stock	Acquisiton	2021-09-07	105	$2.79	169,884	No	4	P	Direct
Common Stock	Acquisiton	2021-09-08	105	$2.89	169,989	No	4	P	Direct
Common Stock	Acquisiton	2021-09-09	105	$2.77	170,094	No	4	P	Direct
Common Stock	Acquisiton	2021-09-10	105	$2.78	170,199	No	4	P	Direct
Common Stock	Acquisiton	2021-09-13	105	$2.96	170,304	No	4	P	Direct
Common Stock	Acquisiton	2021-09-14	105	$3.02	170,409	No	4	P	Direct
Common Stock	Acquisiton	2021-09-15	105	$2.86	170,514	No	4	P	Direct
Common Stock	Acquisiton	2021-09-16	105	$2.91	170,619	No	4	P	Direct
Common Stock	Acquisiton	2021-09-17	105	$2.85	170,724	No	4	P	Direct
Common Stock	Acquisiton	2021-09-20	105	$2.82	170,829	No	4	P	Direct
Common Stock	Acquisiton	2021-09-21	105	$2.81	170,934	No	4	P	Direct
Common Stock	Acquisiton	2021-09-22	105	$2.76	171,039	No	4	P	Direct
Common Stock	Acquisiton	2021-09-23	105	$2.75	171,144	No	4	P	Direct
Common Stock	Acquisiton	2021-09-24	105	$2.74	171,249	No	4	P	Direct
Common Stock	Acquisiton	2021-09-27	105	$2.79	171,354	No	4	P	Direct
Common Stock	Acquisiton	2021-09-28	105	$2.76	171,459	No	4	P	Direct
Common Stock	Acquisiton	2021-09-29	105	$2.82	171,564	No	4	P	Direct
Common Stock	Acquisiton	2021-09-30	105	$2.72	171,669	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.